Dosage: 10 to 50 mg/kg of weight/daily
Gallbladder problems: Some patients may develop gallstones or gallbladder inflammation, especially with higher doses, long-term use, or rapid weight loss
The activation of the OR10P1 receptor by binding famsin results in enhanced expression the gluconeogenic genes encoding glucose-6-phosphatase (G6PC) and the cytosolic version of phosphoenolpyruvate carboxykinase (PCK1), the lipolytic genes encoding carboxy ester lipase (CEL), pancreatic lipase (PNLIP), pancreatic lipase-related protein 2 (PNLIPRP2), and colipase (CLPS), the ketogenic gene encoding mitochondrial HMG-CoA synthase (HMGCS2), and the lipid oxidation gene encoding carnitine palmitoyltransferase 1 (CPT1A)
doi: 10.1152/ajpheart.00146.2010 41 MilanGRomanelloVPescatoreFArmaniAPaikJHFrassonLet al
It is good to watch how your body feels
For patients with mild renal insufficiency: (creatinine clearance [CrCl] 50 mL/min, approximately corresponding to serum creatinine levels of 1 Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin : When JANUVIA is used in combination with an insulin secretagogue (e.g., sulfonylurea) or with insulin, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia